Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Operating activities:
Net income (loss)	$ 5,051	$ (1,153)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Amortization of acquisition-related intangible assets	10,579	10,890
Stock-based compensation plan expense	21,891	16,540
Depreciation and other amortization	11,191	9,543
Gain on sale of cost-method investment	(237)
Deferred income tax benefit	(6,177)	(4,745)
Provision for allowances on accounts receivable	159	75
Amortization of debt issuance costs	208	711
Amortization of debt discount		5,574
Amortization of discount on investments	(75)	(5)
Loss (gain) on disposal of equipment	594	(10)
Loss (gain) on foreign exchange	326	(26)
Changes in operating assets and liabilities:
Accounts receivable	8,827	(12,326)
Prepaid expenses and other current assets	(1,982)	(1,089)
Other assets	(1,643)	926
Accounts payable	403	(145)
Accrued expenses	(4,858)	(1,932)
Customer account liabilities	2,761	(4,588)
Deferred revenue	(13,491)	(12,443)
Other liabilities	(278)	(697)
Net cash provided by operating activities	33,249	5,100
Investing activities:
Acquisition of businesses and assets, net of cash and restricted cash acquired	(8,895)	(5,741)
Proceeds from sale of cost-method investment	237
Purchases of available-for-salesecurities	(7,588)	(9,935)
Proceeds from sales of available-for-sale securities	9,200	1,903
Capital expenditures, including capitalization of software costs	(17,028)	(9,137)
Proceeds from disposal of property and equipment		10
Insurance proceeds received for damage to equipment	200
Net cash used in investing activities	(23,874)	(22,900)
Financing activities:
Repayment of amounts borrowed under revolving credit facility	(40,000)	(189,750)
Amounts borrowed under revolving credit facility		150,000
Repayment of notes payable	(183)	(2,204)
Settlement of warrants	(4)
Debt issuance costs related to credit facility	(597)
Proceeds from exercise of stock options and employee stock purchase plan	1,740	1,705
Net cash used in financing activities	(39,044)	(40,249)
Effect of exchange rate changes on cash	(1,923)	1,012
Decrease in cash, cash equivalents and restricted cash	(31,592)	(57,037)
Cash, cash equivalents and restricted cash at beginning of period	124,613	124,569
Cash, cash equivalents and restricted cash at end of period	93,021	67,532
Cash, cash equivalents and restricted cash at end of period	87,639	64,051
Cash held for customers at end of period	5,382	3,481
Cash, cash equivalents and restricted cash at end of period	93,021	67,532
Supplemental disclosures of non-cash financing activities:
Issuance of common stock upon settlement of the warrants	$ 58,451
Issuance of note payable to seller in connection with acquisition		1,836
Issuance of common stock upon conversion of convertible senior notes		19,736
Receipt of common stock upon settlement of Note Hedges		$ 19,964